Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT
Authors:
- 9 August 2010
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 46 (5) , 682-689
Abstract
Patients undergoing auto-SCT for neuroblastoma present a unique population to study transplant-associated thrombotic microangiopathy (TA-TMA), due to standardized chemotherapy and later exposure to radiation and cis-retinoic acid (cis-RA). We retrospectively analyzed 20 patients after auto-SCT to evaluate early clinical indicators of TA-TMA. A total of 6 patients developing TA-TMA (30% prevalence) were compared with 14 controls. Four of six patients were diagnosed with TA-TMA by 25 days after auto-SCT. Compared with controls, TA-TMA patients had higher average systolic and diastolic blood pressure levels during high-dose chemotherapy and developed hypertension by day 13 after auto-SCT. Proteinuria was a significant marker for TA-TMA, whereas blood and platelet transfusion requirements were not. Serum creatinine did not differ between groups post transplant. However, patients with TA-TMA had a 60% decrease in renal function from baseline by nuclear glomerular filtration rate, compared with a 25% decrease in those without TA-TMA (P=0.001). There was no TA-TMA-related mortality. Significant complications included end-stage renal disease (n=1) and polyserositis (n=3). Patients with TA-TMA were unable to complete cis-RA therapy after auto-SCT. We suggest that careful attention to blood pressure and urinalysis will assist in the early diagnosis of TA-TMA, whereas serum creatinine seems to be an insensitive marker for this condition.Keywords
This publication has 31 references indexed in Scilit:
- Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteriaTransfusion, 2009
- Thrombotic Microangiopathy in Haematopoietic Stem Cell TransplantationDrugs, 2009
- Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorderBone Marrow Transplantation, 2008
- Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?Bone Marrow Transplantation, 2007
- Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximabBritish Journal of Haematology, 2007
- Risk Factors and Severe Outcome in Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem Cell TransplantationTransplantation, 2006
- Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantationBone Marrow Transplantation, 2002
- Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantationBone Marrow Transplantation, 2000
- Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantationBone Marrow Transplantation, 1999
- Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?Bone Marrow Transplantation, 1997